Matthew Leads a team of approximately 20 associates across 3 sites globally who are responsible for delivering the companion diagnostic and exploratory biomarker strategy for programs within the Oncology development portfolio.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)